Dashboard
Manage Tickers

MIST Milestone Pharmaceuticals Inc.

Nasdaq milestonepharma.com


$ 2.04 $ 0.00 (-0.25 %)    

Wednesday, 15-Oct-2025 12:42:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 601.97 $ -1.85 (-0.31 %)
DIA $ 463.20 $ -1.44 (-0.31 %)
SPY $ 664.47 $ -2.37 (-0.35 %)
TLT $ 90.75 $ -0.21 (-0.23 %)
GLD $ 386.15 $ 0.22 (0.06 %)
$ 2.05
$ 2.08
$ 2.03 x 2,122
$ 2.05 x 500
$ 2.03 - $ 2.08
$ 0.63 - $ 2.75
1,753,692
na
174.24M
$ 1.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-13-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-13-2024 03-31-2024 10-Q
7 03-21-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-29-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-10-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-24-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-11-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
19 03-29-2021 12-31-2020 10-K
20 11-13-2020 09-30-2020 10-Q
21 08-12-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 03-06-2020 12-31-2019 10-K
24 11-13-2019 09-30-2019 10-Q
25 08-13-2019 06-30-2019 10-Q
26 06-19-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wells-fargo-initiates-coverage-on-milestone-pharmaceuticals-with-overweight-rating-announces-price-target-of-4
Wells Fargo Initiates Coverage On Mileston...
09/11/2025 11:57:52

Wells Fargo analyst Mohit Bansal initiates coverage on Milestone Pharmaceuticals (NASDAQ:MIST) with a Overweight rating and ...

milestone-pharmaceuticals-q2-eps-020-misses-017-estimate
Milestone Pharmaceuticals Q2 EPS $(0.20) M...
08/12/2025 11:15:37

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.20) per share which missed the analyst consensus estim...

crude-oil-rises-sharply-milestone-pharmaceuticals-shares-plunge
Crude Oil Rises Sharply; Milestone Pharmac...
07/11/2025 18:37:03

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
07/11/2025 17:06:03

why-is-milestone-pharmaceuticals-stock-plunging-on-friday
Why Is Milestone Pharmaceuticals Stock Plu...
07/11/2025 16:22:43

FDA accepts Milestone's response on Cardamyst nasal spray, sets new PDUFA date; company raises $52.5 million to support pot...

dow-dips-over-200-points-levi-strauss-posts-upbeat-earnings
Dow Dips Over 200 Points; Levi Strauss Pos...
07/11/2025 14:41:37

milestone-pharma-prices-525m-equity-offering-with-warrants-offering-is-expected-to-close-on-or-about-july-14-2025
Milestone Pharma Prices $52.5M Equity Offe...
07/11/2025 13:34:18

Milestone® Pharmaceuticals Inc. ("Milestone") (NASDAQ:MIST), a biopharmaceutical company focused on the development and...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
07/11/2025 12:07:13

milestone-pharmaceuticals-launches-public-offering-to-fund-cardamyst-development-includes-warrants-and-pre-funded-shares
Milestone Pharmaceuticals Launches Public ...
07/11/2025 10:06:12

milestone-pharmaceuticals-secures-fda-review-acceptance-for-cardamyst-extends-75m-royalty-deal-with-rtw-through-2025
Milestone Pharmaceuticals Secures FDA Revi...
07/11/2025 10:05:34

milestone-pharmaceuticals-submits-a-response-to-fdas-crl-for-cardamyst-nasal-spray-following-type-a-meeting
Milestone Pharmaceuticals Submits A Respon...
06/16/2025 12:06:18

hc-wainwright--co-assumes-milestone-pharmaceuticals-at-buy-announces-price-target-of-5
HC Wainwright & Co. Assumes Milestone Phar...
06/05/2025 11:13:33

HC Wainwright & Co. analyst Brandon Folkes assumes Milestone Pharmaceuticals (NASDAQ:MIST) with a Buy rating and announc...

milestone-pharmaceuticals-q1-eps-031-misses-018-estimate
Milestone Pharmaceuticals Q1 EPS $(0.31) M...
05/14/2025 11:13:14

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.31) per share which missed the analyst consensus estim...

hc-wainwright--co-maintains-buy-on-milestone-pharmaceuticals-lowers-price-target-to-10
HC Wainwright & Co. Maintains Buy on Miles...
04/01/2025 16:34:44

HC Wainwright & Co. analyst Patrick Trucchio maintains Milestone Pharmaceuticals (NASDAQ:MIST) with a Buy and lowers the...

hc-wainwright--co-reiterates-buy-on-milestone-pharmaceuticals-maintains-25-price-target
HC Wainwright & Co. Reiterates Buy on Mile...
03/28/2025 17:37:49

HC Wainwright & Co. analyst Patrick Trucchio reiterates Milestone Pharmaceuticals (NASDAQ:MIST) with a Buy and maintains...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
03/28/2025 17:05:40

why-is-milestone-pharmaceuticals-stock-plunging-today
Why Is Milestone Pharmaceuticals Stock Plu...
03/28/2025 13:58:51

Milestone Pharmaceuticals' stock drops over 61% after receiving a Complete Response Letter from the FDA for its CARDAMYST NDA.

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
03/28/2025 12:05:48

milestone-pharmaceuticals-says-fda-issued-complete-response-letter-regarding-its-new-drug-application-for-cardamyst-nasal-spray
Milestone Pharmaceuticals Says FDA Issued ...
03/28/2025 11:01:51

The FDA did not raise any concerns regarding etripamil clinical safety or efficacy data and highlighted two key Chemistry, Manu...

hc-wainwright--co-reiterates-buy-on-milestone-pharmaceuticals-maintains-25-price-target
HC Wainwright & Co. Reiterates Buy on Mile...
03/17/2025 15:11:13

HC Wainwright & Co. analyst Patrick Trucchio reiterates Milestone Pharmaceuticals (NASDAQ:MIST) with a Buy and maintains...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION